Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Abuse Potential and Safety

Summary

This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.

Eligibility

Age range

18–55 years

Sex

All

Healthy volunteers

Yes

Interventions

• Drug
  Inhaled vaporized cannabis

  Double-blind cannabis and placebo doses, administered through vaporizer

• Drug
  Intransal opioid

  Double-blind opioid and placebo doses, administered intranasal route

Location